Skip to main content

Advertisement

Log in

Bone health in subjects with type 1 diabetes for more than 50 years

  • Original Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

Aims

Few data regarding prevalence of and risk factors for poor bone health in aging individuals with long-standing T1D are available. In this study, we aim to describe the prevalence of bone fragility and to identify factors associated with low bone density in individuals with long-term T1D.

Methods

We examined the prevalence of non-vertebral fractures in 985 subjects enrolled in the Joslin 50-Year Medalist Study and measured bone mineral density (BMD) by dual-energy X-ray absorptiometry at the femoral neck, lumbar spine and radius in a subset (65 subjects, mean age 62.6 years, duration 52.5 years, HbA1c 7.1%) with no significant clinical or demographic differences from the rest of the cohort.

Results

Medalists have low prevalence of fractures (0.20% hip and 0.91% wrist) and normal Z-score values (spine +1.15, total hip +0.23, femoral neck −0.01, radius +0.26; p > 0.05 for differences vs. 0 at all sites). A significant relationship was found between lower BMD and higher total cholesterol, triglycerides and LDL levels, but not HbA1c. Low BMD at the femoral neck was associated with cardiovascular disease after adjustment for confounding factors: prevalence risk ratio of CVD [95% CI] 4.6 [1.2–18.1], p = 0.03. No other diabetic vascular complication was found to be associated with low BMD.

Conclusions

These are the first data regarding bone health in aging individuals who have had diabetes for 50 or more years. The low rates of non-vertebral fractures and the normal Z-score suggest the long T1D diabetes duration did not increase the risk of bone fractures in Medalists compared to non-diabetic peers. Additionally, the association with cardiovascular disease demonstrates the BMD differences in groups are likely not due to glycemic control alone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

ACR:

Albumin-to-creatinine ratio

BMD:

Bone mineral density

CTx:

Collagen type 1 C-telopeptide

CVD:

Cardiovascular disease

DXA:

Dual-energy X-ray absorptiometry

eGFR:

Estimated glomerular filtration rate

FSH:

Follicle-stimulating hormone

hsCRP:

High-sensitivity C-reactive protein

LH:

Luteinizing hormone

PDR:

Proliferative diabetic retinopathy

PTHi:

Intact parathyroid hormone

SHBG:

Sex hormone binding globulin

T1D:

Type 1 diabetes

References

  1. Janghorbani M, Van Dam RM, Willett WC, Hu FB (2007) Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166:495–505. doi:10.1093/aje/kwm106

    Article  PubMed  Google Scholar 

  2. Maddaloni E, D’Onofrio L, Lauria A et al (2014) Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes. J Endocrinol Invest 37:661–666. doi:10.1007/s40618-014-0092-7

    Article  CAS  PubMed  Google Scholar 

  3. McCabe LR (2007) Understanding the pathology and mechanisms of type I diabetic bone loss. J Cell Biochem 102:1343–1357. doi:10.1002/jcb.21573

    Article  CAS  PubMed  Google Scholar 

  4. Onder A, Cetinkaya S, Tunc O, Aycan Z (2013) Evaluation of bone mineral density in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 26:1077–1081. doi:10.1515/jpem-2012-0369

    Article  CAS  PubMed  Google Scholar 

  5. Joshi A, Varthakavi P, Chadha M, Bhagwat N (2013) A study of bone mineral density and its determinants in type 1 diabetes mellitus. J Osteoporos 2013:397814. doi:10.1155/2013/397814

    Article  PubMed  PubMed Central  Google Scholar 

  6. Miazgowski T, Czekalski S (1998) A 2-year follow-up study on bone mineral density and markers of bone turnover in patients with long-standing insulin-dependent diabetes mellitus. Osteoporos Int 8:399–403. doi:10.1007/s001980050082

    Article  CAS  PubMed  Google Scholar 

  7. Ingberg C-M, Palmér M, Aman J et al (2004) Body composition and bone mineral density in long-standing type 1 diabetes. J Intern Med 255:392–398

    Article  PubMed  Google Scholar 

  8. Strotmeyer ES, Cauley JA, Orchard TJ et al (2006) Middle-aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than nondiabetic women. Diabetes Care 29:306–311. doi:10.2337/diacare.29.02.06.dc05-1353

    Article  PubMed  Google Scholar 

  9. Livingstone SJ, Levin D, Looker HC et al (2015) Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010. JAMA 313:37–44. doi:10.1001/jama.2014.16425

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Miller RG, Secrest AM, Sharma RK et al (2012) Improvements in the life expectancy of type 1 diabetes: the Pittsburgh epidemiology of diabetes complications study cohort. Diabetes 61:2987–2992. doi:10.2337/db11-1625

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Petrie D, Lung TWC, Rawshani A et al (2016) Recent trends in life expectancy for people with type 1 diabetes in Sweden. Diabetologia 59:1167–1176. doi:10.1007/s00125-016-3914-7

    Article  PubMed  Google Scholar 

  12. Huo L, Shaw JE, Wong E et al (2016) Burden of diabetes in Australia: life expectancy and disability-free life expectancy in adults with diabetes. Diabetologia 59:1437–1445. doi:10.1007/s00125-016-3948-x

    Article  PubMed  Google Scholar 

  13. Keenan HA, Maddaloni E (2016) Bone microarchitecture in type 1 diabetes: it is complicated. Curr Osteoporos Rep 14:351–358. doi:10.1007/s11914-016-0338-8

    Article  PubMed  Google Scholar 

  14. Keenan HA, Costacou T, Sun JK et al (2007) Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year Medalist study. Diabetes Care 30:1995–1997. doi:10.2337/dc06-2222

    Article  CAS  PubMed  Google Scholar 

  15. Keenan HA, Sun JK, Levine J et al (2010) Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 59:2846–2853. doi:10.2337/db10-0676

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Sun JK, Keenan HA, Cavallerano JD et al (2011) Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the Joslin 50-year Medalist study. Diabetes Care 34:968–974. doi:10.2337/dc10-1675

    Article  PubMed  PubMed Central  Google Scholar 

  17. Martin LM, Leff M, Calonge N et al (2000) Validation of self-reported chronic conditions and health services in a managed care population. Am J Prev Med 18:215–218

    Article  CAS  PubMed  Google Scholar 

  18. Feldman EL, Stevens MJ, Thomas PK et al (1994) A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17:1281–1289

    Article  CAS  PubMed  Google Scholar 

  19. Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612

    Article  PubMed  PubMed Central  Google Scholar 

  20. (1991) Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98:823–833

  21. Kanis JA, Melton LJ, Christiansen C et al (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:1137–1141. doi:10.1002/jbmr.5650090802

    Article  CAS  PubMed  Google Scholar 

  22. Weber DR, Haynes K, Leonard MB et al (2015) Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using the health improvement network (thin). Diabetes Care. doi:10.2337/dc15-0783

    Google Scholar 

  23. Wright NC, Looker AC, Saag KG et al (2014) The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res 29:2520–2526. doi:10.1002/jbmr.2269

    Article  PubMed  PubMed Central  Google Scholar 

  24. Kemink SA, Hermus AR, Swinkels LM et al (2000) Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. J Endocrinol Invest 23:295–303

    Article  CAS  PubMed  Google Scholar 

  25. Bridges MJ, Moochhala SH, Barbour J, Kelly CA (2005) Influence of diabetes on peripheral bone mineral density in men: a controlled study. Acta Diabetol 42:82–86. doi:10.1007/s00592-005-0183-1

    Article  CAS  PubMed  Google Scholar 

  26. Lunt H, Florkowski CM, Cundy T et al (1998) A population-based study of bone mineral density in women with longstanding type 1 (insulin dependent) diabetes. Diabetes Res Clin Pract 40:31–38

    Article  CAS  PubMed  Google Scholar 

  27. He ZH, D’Eon SA, Tinsley LJ et al (2015) Cardiovascular disease protection in long-duration type 1 diabetes and sex differences. Diabetes Care 38:e73–e74. doi:10.2337/dc15-0017

    Article  PubMed  PubMed Central  Google Scholar 

  28. Fiorina P, Folli F, Maffi P et al (2003) Islet transplantation improves vascular diabetic complications in patients with diabetes who underwent kidney transplantation: a comparison between kidney-pancreas and kidney-alone transplantation. Transplantation 75:1296–1301. doi:10.1097/01.TP.0000061788.32639.D9

    Article  PubMed  Google Scholar 

  29. Bassi R, Fiorina P (2011) Impact of islet transplantation on diabetes complications and quality of life. Curr Diab Rep 11:355–363. doi:10.1007/s11892-011-0211-1

    Article  PubMed  Google Scholar 

  30. Pozzilli P, Maddaloni E, Buzzetti R (2015) Combination immunotherapies for type 1 diabetes mellitus. Nat Rev Endocrinol 11:289–297. doi:10.1038/nrendo.2015.8

    Article  CAS  PubMed  Google Scholar 

  31. Miao J, Brismar K, Nyrén O et al (2005) Elevated hip fracture risk in type 1 diabetic patients: a population-based cohort study in Sweden. Diabetes Care 28:2850–2855

    Article  PubMed  Google Scholar 

  32. Shanbhogue VV, Hansen S, Frost M et al (2015) Bone geometry, volumetric density, microarchitecture, and estimated bone strength assessed by HR-pQCT in adult patients with type 1 diabetes mellitus. J Bone Miner Res 30:2188–2199. doi:10.1002/jbmr.2573

    Article  CAS  PubMed  Google Scholar 

  33. Bagger YZ, Rasmussen HB, Alexandersen P et al (2007) Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se? Osteoporos Int 18:505–512. doi:10.1007/s00198-006-0255-2

    Article  CAS  PubMed  Google Scholar 

  34. Makovey J, Chen JS, Hayward C et al (2009) Association between serum cholesterol and bone mineral density. Bone 44:208–213. doi:10.1016/j.bone.2008.09.020

    Article  CAS  PubMed  Google Scholar 

  35. Yerges-Armstrong LM, Shen H, Ryan KA et al (2013) Decreased bone mineral density in subjects carrying familial defective apolipoprotein B-100. J Clin Endocrinol Metab 98:E1999–E2005. doi:10.1210/jc.2013-2471

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Parhami F, Garfinkel A, Demer LL (2000) Role of lipids in osteoporosis. Arterioscler Thromb Vasc Biol 20:2346–2348

    Article  CAS  PubMed  Google Scholar 

  37. Parhami F, Jackson SM, Tintut Y et al (1999) Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J Bone Miner Res 14:2067–2078. doi:10.1359/jbmr.1999.14.12.2067

    Article  CAS  PubMed  Google Scholar 

  38. Patsch JM, Burghardt AJ, Yap SP et al (2013) Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures. J Bone Miner Res 28:313–324. doi:10.1002/jbmr.1763

    Article  PubMed  PubMed Central  Google Scholar 

  39. Yu EW, Putman MS, Derrico N et al (2015) Defects in cortical microarchitecture among African–American women with type 2 diabetes. Osteoporos Int 26:673–679. doi:10.1007/s00198-014-2927-7

    Article  CAS  PubMed  Google Scholar 

  40. Farr JN, Drake MT, Amin S et al (2014) In vivo assessment of bone quality in postmenopausal women with type 2 diabetes. J Bone Miner Res 29:787–795. doi:10.1002/jbmr.2106

    Article  PubMed  PubMed Central  Google Scholar 

  41. Kinoshita H, Tamaki T, Hashimoto T, Kasagi F (1998) Factors influencing lumbar spine bone mineral density assessment by dual-energy X-ray absorptiometry: comparison with lumbar spinal radiogram. J Orthop Sci 3:3–9

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank the staff the Joslin Clinical Research Center and the 50-Year Medalists and their families. Additionally, we express our appreciation to Dr. George King for his input.

Funding

The Medalist Study was supported by grants from the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (DP3 DK094333-01). Financial support for this work was provided by the NIDDK Diabetic Complications Consortium (DiaComp, www.diacomp.org), grant DK076169’, the Juvenile Diabetes Research Foundation (17-2013-310); and the Beatson Foundation. E.M. was in part supported by the Albert Renold Travel Fellowship of the European Foundation for the Study of Diabetes (EFSD).

Author Contributions

EM analyzed data, interpreted data and wrote the manuscript. SD, SH, SMRF and LT helped collect and analyze the data and edited the manuscript. MK, MB and NN contributed to the content and edited the manuscript. HK conceived and designed the study, analyzed and interpreted data and wrote the manuscript. All authors contributed to, read and approved the final version of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hillary A. Keenan.

Ethics declarations

Conflict of interest

None.

Ethical standard

The Joslin Committee on Human Studies approved the study protocol.

Human and animal rights

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5).

Informed consent

Informed consent was obtained from all patients for being included in the study.

Additional information

Managed by Massimo Federici.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 19 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maddaloni, E., D’Eon, S., Hastings, S. et al. Bone health in subjects with type 1 diabetes for more than 50 years. Acta Diabetol 54, 479–488 (2017). https://doi.org/10.1007/s00592-017-0973-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-017-0973-2

Keywords

Navigation